FBLN5 and neoplasm: Fibulin-5 also inhibited transactivation of the TOPFlash reporter by wild-type (WT) β-catenin, and that by a tumor-derived mutant β-catenin lacking the amino-terminal phosphorylation sites (ΔN) required for its degradation (Fig. 3D).